TR200001600T2 - Aril -8-oksodihidropurin türevleri, üretim prosesleri, bunları içeren farmasötik terkipler, ve ara ürünleri. - Google Patents

Aril -8-oksodihidropurin türevleri, üretim prosesleri, bunları içeren farmasötik terkipler, ve ara ürünleri.

Info

Publication number
TR200001600T2
TR200001600T2 TR2000/01600T TR200001600T TR200001600T2 TR 200001600 T2 TR200001600 T2 TR 200001600T2 TR 2000/01600 T TR2000/01600 T TR 2000/01600T TR 200001600 T TR200001600 T TR 200001600T TR 200001600 T2 TR200001600 T2 TR 200001600T2
Authority
TR
Turkey
Prior art keywords
aryl
intermediates
pharmaceutical compositions
compositions containing
production processes
Prior art date
Application number
TR2000/01600T
Other languages
English (en)
Inventor
Murata Teruya
Masumoto Kaoru
Kondo Katsunori
Furukawa Kiyoshi
Oka Makoto
Original Assignee
Dainippon Pharmaceutical Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dainippon Pharmaceutical Co., Ltd. filed Critical Dainippon Pharmaceutical Co., Ltd.
Publication of TR200001600T2 publication Critical patent/TR200001600T2/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Abstract

Genel formül (1) ile temsil edilen 2-aril-8-oksodihidropürin türevleri ve farmasötik olarak kabul edilir asit katki tuzlari. Bu bilesimler, anksiyete ile ilgili hastaliklar (nevroz, psiko-fizyolojik bozukluklar, anksiyete hastaliklari vs), depresyon ve epilepsi gibi merkezi sinir sistemi hastaliklari ve anjin pektoris ve yüksek tansiyon gibi dolasim hastaliklari için tedavi ve önlemede kullanilir. Bahsi geçen formülde;a, tercihe göre ikameli fenil veya heteroaril olup, X veya y ise [Q] :-CH(R3)CON(R1)(R2)'dir.
TR2000/01600T 1997-12-03 1998-11-26 Aril -8-oksodihidropurin türevleri, üretim prosesleri, bunları içeren farmasötik terkipler, ve ara ürünleri. TR200001600T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP35000097 1997-12-03

Publications (1)

Publication Number Publication Date
TR200001600T2 true TR200001600T2 (tr) 2000-11-21

Family

ID=18407561

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2000/01600T TR200001600T2 (tr) 1997-12-03 1998-11-26 Aril -8-oksodihidropurin türevleri, üretim prosesleri, bunları içeren farmasötik terkipler, ve ara ürünleri.

Country Status (27)

Country Link
US (1) US6372740B1 (tr)
EP (1) EP1036794B1 (tr)
JP (1) JP3815966B2 (tr)
KR (1) KR100494347B1 (tr)
CN (1) CN1146566C (tr)
AR (1) AR017796A1 (tr)
AT (1) ATE248169T1 (tr)
AU (1) AU744014B2 (tr)
BR (1) BR9815140A (tr)
CA (1) CA2312885C (tr)
DE (1) DE69817611T2 (tr)
DK (1) DK1036794T3 (tr)
ES (1) ES2205574T3 (tr)
HK (1) HK1028769A1 (tr)
HU (1) HUP0004422A3 (tr)
ID (1) ID24929A (tr)
IL (1) IL135920A0 (tr)
NO (1) NO20002835L (tr)
NZ (1) NZ504457A (tr)
PL (1) PL191489B1 (tr)
PT (1) PT1036794E (tr)
RU (1) RU2223272C2 (tr)
SK (1) SK285703B6 (tr)
TR (1) TR200001600T2 (tr)
TW (1) TW502034B (tr)
WO (1) WO1999028320A1 (tr)
ZA (1) ZA9810490B (tr)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003146987A (ja) * 1999-05-31 2003-05-21 Dainippon Pharmaceut Co Ltd ２−アリールプリン−９−アセトアミド誘導体
GB9913932D0 (en) * 1999-06-15 1999-08-18 Pfizer Ltd Purine derivatives
BR0014319A (pt) * 1999-09-27 2002-07-16 Ono Pharmaceutical Co Derivados de pirimidina, processo para preparação dos derivados e drogas contendo o mesmos como o ingrediente ativo
KR100829297B1 (ko) * 2000-07-31 2008-05-13 다이닛본 스미토모 세이야꾸 가부시끼가이샤 2-아릴-8-옥소디히드로푸린 유도체를 유효성분으로 하는치매증 치료제
TW200521119A (en) * 2003-08-05 2005-07-01 Vertex Pharma Compositions useful as inhibitors of voltage-gated ion channels
US20070191447A1 (en) * 2004-02-23 2007-08-16 Toru Kodo Novel heterocyclic compound
WO2005115399A2 (en) * 2004-04-16 2005-12-08 Neurogen Corporation Imidazopyrazines, imidazopyridines, ans imidazopyrimidines as crf1 receptor ligands
FR2870239B1 (fr) 2004-05-11 2006-06-16 Sanofi Synthelabo Derives de carbamate de 2h- ou 3h-benzo[e]indazol-1-yle, leur preparation et leur application en therapeutique.
US7884109B2 (en) * 2005-04-05 2011-02-08 Wyeth Llc Purine and imidazopyridine derivatives for immunosuppression
BRPI0610514A2 (pt) * 2005-04-05 2016-11-16 Pharmacopeia Inc composto, composição farmacêutica, e, método de tratamento de um distúrbio
GB0507298D0 (en) 2005-04-11 2005-05-18 Novartis Ag Organic compounds
US20070225304A1 (en) * 2005-09-06 2007-09-27 Pharmacopeia Drug Discovery, Inc. Aminopurine derivatives for treating neurodegenerative diseases
US20090281075A1 (en) * 2006-02-17 2009-11-12 Pharmacopeia, Inc. Isomeric purinones and 1h-imidazopyridinones as pkc-theta inhibitors
US7989459B2 (en) * 2006-02-17 2011-08-02 Pharmacopeia, Llc Purinones and 1H-imidazopyridinones as PKC-theta inhibitors
ZA200807715B (en) * 2006-03-09 2009-11-25 Pharmacopeia Inc 9-Heteroarylpurine MNK2 inhibitors for treating metabolic disorders
US7902187B2 (en) * 2006-10-04 2011-03-08 Wyeth Llc 6-substituted 2-(benzimidazolyl)purine and purinone derivatives for immunosuppression
AR063142A1 (es) * 2006-10-04 2008-12-30 Pharmacopeia Inc Derivados de 2-(bencimidazolil) purina y purinonas 6-sustituidas utiles como inmunosupresores,y composiciones farmaceuticas que los contienen.
AR063141A1 (es) * 2006-10-04 2008-12-30 Pharmacopeia Inc Derivados de 2- ( benzimidazolil ) purina 8- sustituida para inmunosupresion
NZ576278A (en) 2006-10-19 2011-12-22 Signal Pharm Llc Heteroaryl compounds, compositions thereof, and their use as protein kinase inhibitors
US20080119496A1 (en) * 2006-11-16 2008-05-22 Pharmacopeia Drug Discovery, Inc. 7-Substituted Purine Derivatives for Immunosuppression
JP2009007273A (ja) * 2007-06-27 2009-01-15 Ajinomoto Co Inc ジアミノピリミジン化合物の製造方法
US8110578B2 (en) 2008-10-27 2012-02-07 Signal Pharmaceuticals, Llc Pyrazino[2,3-b]pyrazine mTOR kinase inhibitors for oncology indications and diseases associated with the mTOR/PI3K/Akt pathway
US8473571B2 (en) 2009-01-08 2013-06-25 Microsoft Corporation Synchronizing presentation states between multiple applications
AU2010293429B2 (en) * 2009-09-09 2015-12-17 Sumitomo Dainippon Pharma Co., Ltd. 8-oxodihydropurine derivative
EP3091021B1 (en) 2009-10-26 2019-08-28 Signal Pharmaceuticals, LLC Methods of synthesis and purification of heteroaryl compounds
JP2014076947A (ja) * 2011-02-03 2014-05-01 Dainippon Sumitomo Pharma Co Ltd ２−オキシ置換８−オキソジヒドロプリン誘導体
WO2012168697A1 (en) 2011-06-06 2012-12-13 Imperial Innovations Limited Methods to predict binding affinity of tspo imaging agents to tspo
TWI708605B (zh) 2011-10-19 2020-11-01 標誌製藥公司 以ｔｏｒ激酶抑制劑治療癌症
EA026390B1 (ru) 2011-12-02 2017-04-28 СИГНАЛ ФАРМАСЬЮТИКАЛЗ, ЭлЭлСи ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ 7-(6-(2-ГИДРОКСИПРОПАН-2-ИЛ)ПИРИДИН-3-ИЛ)-1-((ТРАНС)-4-МЕТОКСИЦИКЛОГЕКСИЛ)-3,4-ДИГИДРОПИРАЗИНО[2,3-b]ПИРАЗИН-2(1Н)-ОНА, ИХ ТВЕРДЫЕ ФОРМЫ И СПОСОБЫ ИХ ПРИМЕНЕНИЯ
EP2817029B1 (en) 2012-02-24 2019-07-10 Signal Pharmaceuticals, LLC Methods for treating non-small cell lung cancer using tor kinase inhibitor combination therapy
CN102675315B (zh) * 2012-02-28 2015-04-01 中国人民解放军第四军医大学 含取代苯烷基的嘌呤类化合物和制备方法及应用
AU2013203714B2 (en) 2012-10-18 2015-12-03 Signal Pharmaceuticals, Llc Inhibition of phosphorylation of PRAS40, GSK3-beta or P70S6K1 as a marker for TOR kinase inhibitory activity
US9346812B2 (en) 2013-01-16 2016-05-24 Signal Pharmaceuticals, Llc Substituted pyrrolopyrimidine compounds, compositions thereof, and methods of treatment therewith
NZ629230A (en) 2013-04-17 2017-05-26 Signal Pharm Llc Pharmaceutical formulations, processes, solid forms and methods of use relating to 1-ethyl-7-(2-methyl-6-(1h-1,2,4-triazol-3-yl)pyridin-3-yl)-3,4-dihydropyrazino[2,3-b]pyrazin-2(1h)-one
CA2908957C (en) 2013-04-17 2021-05-18 Signal Pharmaceuticals, Llc Combination therapy comprising a dihydropyrazino-pyrazine compound and an androgen receptor antagonist for treating prostate cancer
EP2986321A1 (en) 2013-04-17 2016-02-24 Signal Pharmaceuticals, LLC Combination therapy comprising a tor kinase inhibitor and a cytidine analog for treating cancer
MX2015014455A (es) 2013-04-17 2016-07-21 Signal Pharm Llc Terapia de combinacion que comprende un inhibidor de tor cinasa y n-(3-(5-fluoro-2-(4-(2-metoxietoxi)fenilamino)pirimidin-4-ilamino )fenil)acrilamida para tratar cancer.
NZ629332A (en) 2013-04-17 2017-05-26 Signal Pharm Llc Treatment of cancer with dihydropyrazino-pyrazines
CA2908830C (en) 2013-04-17 2021-12-07 Signal Pharmaceuticals, Llc Treatment of cancer with dihydropyrazino-pyrazines
AU2014253978B2 (en) 2013-04-17 2019-06-06 Signal Pharmaceuticals, Llc Combination therapy comprising a TOR kinase inhibitor and a 5-Substituted Quinazolinone Compound for treating cancer
JP6401250B2 (ja) 2013-05-29 2018-10-10 シグナル ファーマシューティカルズ，エルエルシー ７−（６−（２−ヒドロキシプロパン−２−イル）ピリジン−３−イル）−１−（（ｔｒａｎｓ）−４−メトキシシクロヘキシル）−３，４−ジヒドロピラジノ［２，３−ｂ］ピラジン−２（１Ｈ）−オン、その固体形態の医薬組成物、及びその使用方法
WO2015160880A1 (en) 2014-04-16 2015-10-22 Signal Pharmaceuticals, Llc SOLID FORMS COMPRISING 1-ETHYL-7-(2-METHYL-6-(1H-1,2,4-TRIAZOL-3-YL) PYRIDIN-3-YL)-3,4-DIHYDROPYRAZINO(2,3-b)PYRAZIN-2(1H)-ONE, AND A COFORMER, COMPOSITIONS AND METHODS OF USE THEREOF
US9737535B2 (en) 2014-04-16 2017-08-22 Signal Pharmaceuticals, Llc Methods for treating cancer using TOR kinase inhibitor combination therapy comprising administering substituted pyrazino[2,3-b]pyrazines
WO2015160882A1 (en) 2014-04-16 2015-10-22 Signal Pharmaceuticals, Llc SOLID FORMS COMPRISING 7-(6-(2-HYDROXYPROPAN-2YL) PYRIDIN-3-YL)-1-(TRANS)-4-METHOXYCYCLOHEXYL)-3, 4-DIHYDROPYRAZINO[2,3-b] PYRAZIN-2(1H)-ONE, AND A COFORMER, COMPOSITIONS AND METHODS OF USE THEREOF
NZ714742A (en) 2014-04-16 2017-04-28 Signal Pharm Llc Solid forms of 1-ethyl-7-(2-methyl-6-(1h-1,2,4-triazol-3-yl)pyridin-3-yl)-3,4-dihydropyrazino[2,3-b]pyrazin-2(1h)-one, compositions thereof and methods of their use
NZ629796A (en) 2014-07-14 2015-12-24 Signal Pharm Llc Amorphous form of 4-((4-(cyclopentyloxy)-5-(2-methylbenzo[d]oxazol-6-yl)-7h-pyrrolo[2,3-d]pyrimidin-2-yl)amino)-3-methoxy-n-methylbenzamide, compositions thereof and methods of their use
US9623028B2 (en) 2014-07-14 2017-04-18 Signal Pharmaceuticals, Llc Methods of treating a cancer using substituted pyrrolopyrimidine compounds, compositions thereof
RU2750151C2 (ru) 2015-11-20 2021-06-22 Форма Терапьютикс, Инк. Гипоксантины в качестве ингибиторов убиквитин-специфической протеазы 1
BR112019027402A2 (pt) 2017-06-22 2020-07-07 Celgene Corporation tratamento de carcinoma hepatocelular caracterizado por infecção pelo vírus da hepatite b
WO2019155042A1 (en) 2018-02-12 2019-08-15 F. Hoffmann-La Roche Ag Novel sulfone compounds and derivatives for the treatment and prophylaxis of virus infection

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2525595A1 (fr) 1982-04-27 1983-10-28 Pharmuka Lab Nouveaux derives d'arene et d'heteroarenecarboxamides et leur utilisation comme medicaments
FR2582514B1 (fr) 1985-05-30 1988-02-19 Rhone Poulenc Sante Medicaments a base d'amides, nouveaux amides et leur preparation
DK273689A (da) 1988-06-06 1989-12-07 Sanofi Sa 4-amino-3-carboxyquinoliner og -naphthyridiner, fremgangsmaade til deres fremstilling og anvendelse deraf i laegemidler
FR2632639B1 (fr) 1988-06-09 1990-10-05 Sanofi Sa Derives d'amino-4 carboxy-3 naphtyridines, leur preparation et compositions pharmaceutiques qui les contiennent
US6083953A (en) 1994-07-28 2000-07-04 Syntex (U.S.A.) Inc. 2- (2-amino-1,6-dihydro-6-oxo-purin-9-yl) methoxy-1,3- propanediol derivative
IL117659A (en) 1995-04-13 2000-12-06 Dainippon Pharmaceutical Co Substituted 2-phenyl pyrimidino amino acetamide derivative process for preparing the same and a pharmaceutical composition containing same
ES2232871T3 (es) 1996-07-03 2005-06-01 Sumitomo Pharmaceuticals Company, Limited Nuevos derivados de purina.
JP2002501493A (ja) * 1997-04-22 2002-01-15 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ Ｃｒｆアンタゴニストのチオフェノピリジン類
JP3814125B2 (ja) * 1999-06-02 2006-08-23 大日本住友製薬株式会社 ２−アリール−８−オキソジヒドロプリン誘導体からなる医薬

Also Published As

Publication number Publication date
NO20002835D0 (no) 2000-06-02
NZ504457A (en) 2001-12-21
ATE248169T1 (de) 2003-09-15
CN1146566C (zh) 2004-04-21
ES2205574T3 (es) 2004-05-01
RU2223272C2 (ru) 2004-02-10
SK7972000A3 (en) 2001-03-12
DE69817611D1 (de) 2003-10-02
PT1036794E (pt) 2003-11-28
TW502034B (en) 2002-09-11
EP1036794A1 (en) 2000-09-20
EP1036794B1 (en) 2003-08-27
WO1999028320A1 (fr) 1999-06-10
CA2312885C (en) 2008-01-29
CN1284076A (zh) 2001-02-14
KR20010032686A (ko) 2001-04-25
AU1260499A (en) 1999-06-16
DE69817611T2 (de) 2004-02-26
KR100494347B1 (ko) 2005-06-13
SK285703B6 (sk) 2007-06-07
PL340925A1 (en) 2001-03-12
EP1036794A4 (en) 2001-12-12
HUP0004422A2 (hu) 2001-04-28
NO20002835L (no) 2000-07-24
DK1036794T3 (da) 2003-12-22
HK1028769A1 (en) 2001-03-02
CA2312885A1 (en) 1999-06-10
ZA9810490B (en) 1999-05-20
IL135920A0 (en) 2001-05-20
BR9815140A (pt) 2000-10-10
PL191489B1 (pl) 2006-05-31
AR017796A1 (es) 2001-10-24
ID24929A (id) 2000-08-31
HUP0004422A3 (en) 2001-10-29
AU744014B2 (en) 2002-02-14
JP3815966B2 (ja) 2006-08-30
US6372740B1 (en) 2002-04-16

Similar Documents

Publication Publication Date Title
TR200001600T2 (tr) Aril -8-oksodihidropurin türevleri, üretim prosesleri, bunları içeren farmasötik terkipler, ve ara ürünleri.
ATE265419T1 (de) Spiro(2.4)heptanaminocarbonsäure und ihre derivate
HUP0101999A2 (hu) 4-Hidroxi-kinolin-3-karboxamid- és -hidrazid-származékok, ezeket tartalmazó gyógyászati készítmények, valamint e vegyületek alkalmazása
KR900012911A (ko) 흥분성 아미노산 수용기 길항질 화합물
HRP20020428B1 (en) Bicyclic amino acids as pharmaceutical agents
CA2285037A1 (fr) Nouveaux derives du 2-(iminomethyl)amino-phenyle, leur preparation, leur application a titre de medicaments et les compositions pharmaceutiques les contenant
GEP20053617B (en) Bridged Piperazine Derivatives
RU94046141A (ru) Замещенные производные /арилалкоксибензил/ аминопропанамида, способы их получения, фармацевтическая композиция
HK1046902A1 (zh) 新型哌嗪基烷基硫代嘧啶衍生物，包含該衍生物的藥物組合物以及製備該活性物質的方法
YU51498A (en) 2,4-diaminopyrimidine derivatives
BR9503572A (pt) Composto composiçao farmaceutica e método de tratamento ou prevençao de uma doença
ATE253359T1 (de) Antithrombotische mittel
ES2111352T3 (es) Uso de diester fosfato para el tratamiento de enfermedades retinianas.
HUP0300863A2 (hu) N-(3,5-diklór-2-metoxi-fenil)-4-metoxi-3-(1-piperazinil)-benzolszulfonamid, eljárás elżállítására és a vegyületet tartalmazó gyógyszerkészítmény
EP1607394A4 (en) WATER-SOLUBLE THALIDOMINE DERIVATIVES
HUP0004058A2 (hu) Készítmények és eljárások biológiai membránok permeabilitásának reverzibilis növelésére
SE9702716D0 (sv) Substituted phenylazacycloalkanes in the treatment of cognitive disorders
DK526087A (da) Antikonvulsive aminosyrederivater
ATE286395T1 (de) Antithrombotische mittel
WO2001002340A3 (en) Novel aminoindanes
JO2287B1 (en) Phosphine lysis of azides and amides
PT1025101E (pt) Derivados de nafto-imidazo¬1,2-a|piridina sua preparacao e uso no tratamento de perturbacoes do sistema nervoso central
TR199900013T2 (tr) Yeni bilesikler.
CA2235053A1 (fr) Nouveaux composes amines du 6,7,8,9-tetrahydro-cyclopenta¬a|naphtalene et du 2,3-dihydro-cyclopenta, ¬e|indene, leur procede de preparation et les compositions pharmaceutiques quiles contiennent
HUP0004734A1 (hu) Gyógyászatilag hatásos új vegyületek, eljárás előállításukra és alkalmazásuk ECE-inhibitorként